Last updated on July 2019

An Open-Label Multi-Centre Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.


Brief description of study

To evaluate the safety, tolerability, and anti-tumor activity of the combination of durvalumab + tremelimumab or durvalumab alone in different solid tumors.

Detailed Study Description

This is an open-label, multi-center, study to determine the short and long term safety of fixed doses of durvalumab 1500 mg + tremelimumab 75 mg combination therapy or durvalumab 1500 mg monotherapy in patients with advanced solid malignancies. This study is modular in design, one or more of the modules will be opened in a given country / region based on local patient population prevalence, and results of feasibility studies. The total number of patients to be enrolled overall and in each module will depend on the types and number of tumor modules added to the main study and country-specific ancillary studies. The number of patients and sites to be involved in individual countries will be dependent on each module or ancillary study. This study consisted of a screening period, a treatment period, a 90 day safety follow-up period and a survival follow-up period. Patients will receive the investigation product (IP) via intravenous (IV) infusion once every 4 weeks (Q4W) in combination therapy or monotherapy as mentioned below - Combination therapy: Durvalumab 1,500 mg + tremelimumab 75 mg on Week 0, for up to a maximum of 4 doses (or cycles) followed by durvalumab 1,500 mg starting 4 weeks after the last infusion of the combination or discontinuation of tremelimumab.

Monotherapy: Durvalumab 1,500 mg on week 0.

Patients will attend a safety follow-up visit 90 days after study treatment discontinuation. Thereafter, patients will be contacted by phone or electronic communication every 3 months for survival status up to 5 years following date of first patient treatment initiation. All patients will be followed for a minimum of 6 months following enrolment of last patient. It is anticipated that the total enrolment period for the overall study will be approximately 2 to 3 years, with an overall duration of approximately 5 years.

Clinical Study Identifier: NCT03084471

Find a site near you

Start Over

Research Site

Anchorage, AK United States
  Connect »

Research Site

Chandler, AZ United States
  Connect »

Research Site

Escondido, CA United States
  Connect »

Research Site

Los Angeles, CA United States
  Connect »

Research Site

Mather, CA United States
  Connect »

Research Site

San Diego, CA United States
  Connect »

Research Site

Santa Rosa, CA United States
  Connect »

Research Site

Whittier, CA United States
  Connect »

Research Site

New Haven, CT United States
  Connect »

Research Site

Newark, DE United States
  Connect »

Research Site

Washington, WA United States
  Connect »

Research Site

Fort Myers, FL United States
  Connect »

Research Site

Miami Lakes, FL United States
  Connect »

Research Site

Miami, FL United States
  Connect »

Research Site

Orlando, FL United States
  Connect »

Research Site

West Palm Beach, FL United States
  Connect »

Research Site

Athens, GA United States
  Connect »

Research Site

Atlanta, GA United States
  Connect »

Research Site

Decatur, GA United States
  Connect »

Research Site

Skokie, IL United States
  Connect »

Research Site

Tinley Park, IL United States
  Connect »

Research Site

Ames, IA United States
  Connect »

Research Site

Baltimore, MD United States
  Connect »

Research Site

Hagerstown, MD United States
  Connect »

Research Site

Ann Arbor, MI United States
  Connect »

Research Site

Lansing, MI United States
  Connect »

Research Site

Minneapolis, MN United States
  Connect »

Research Site

Kansas City, MO United States
  Connect »

Research Site

Billings, MT United States
  Connect »

Research Site

Omaha, NE United States
  Connect »

Research Site

Hackensack, NJ United States
  Connect »

Research Site

Summit, NJ United States
  Connect »

Research Site

Voorhees, NJ United States
  Connect »

Research Site

East Setauket, NY United States
  Connect »

Research Site

Lake Success, NY United States
  Connect »

Research Site

New Hyde Park, NY United States
  Connect »

Research Site

White Plains, NY United States
  Connect »

Research Site

Charlotte, NC United States
  Connect »

Research Site

Greenville, NC United States
  Connect »

Research Site

Salisbury, NC United States
  Connect »

Research Site

Winston-Salem, NC United States
  Connect »

Research Site

Oklahoma City, OK United States
  Connect »

Research Site

Portland, OR United States
  Connect »

Research Site

Philadelphia, PA United States
  Connect »

Research Site

Providence, RI United States
  Connect »

Research Site

Rock Hill, SC United States
  Connect »

Research Site

Seneca, SC United States
  Connect »

Research Site

Sioux Falls, SD United States
  Connect »

Research Site

Knoxville, TN United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Fort Worth, TX United States
  Connect »

Research Site

Houston, TX United States
  Connect »

Research Site

Tyler, TX United States
  Connect »

Research Site

Blacksburg, VA United States
  Connect »

Research Site

Chesapeake, VA United States
  Connect »

Research Site

Fairfax, VA United States
  Connect »

Research Site

Fort Belvoir, VA United States
  Connect »

Research Site

Lacey, WA United States
  Connect »

Research Site

Olympia, WA United States
  Connect »

Research Site

Spokane, WA United States
  Connect »

Research Site

Milwaukee, WI United States
  Connect »

Research Site

Calgary, AB Canada
  Connect »

Research Site

Winnipeg, MB Canada
  Connect »

Research Site

Moncton, NB Canada
  Connect »

Research Site

Brampton, ON Canada
  Connect »

Research Site

Hamilton, ON Canada
  Connect »

Research Site

Kingston, ON Canada
  Connect »

Research Site

London, ON Canada
  Connect »

Research Site

Newmarket, ON Canada
  Connect »

Research Site

Oshawa, ON Canada
  Connect »

Research Site

Toronto, ON Canada
  Connect »

Research Site

Greenfield Park, QC Canada
  Connect »

Research Site

Montreal, QC Canada
  Connect »

Research Site

Sherbrooke, QC Canada
  Connect »

Research Site

Quebec, QC Canada
  Connect »

Research Site

Besançon Cedex, France
  Connect »

Research Site

Bordeaux Cedex, France
  Connect »

Research Site

Lille Cedex, France
  Connect »

Research Site

Lyon Cedex 08, France
  Connect »

Research Site

Marseille, France
  Connect »

Research Site

Montpellier, France
  Connect »

Research Site

Pierre Benite, France
  Connect »

Research Site

Poitiers Cedex, France
  Connect »

Research Site

Saint Herblain Cedex, France
  Connect »

Research Site

Strasbourg Cedex, France
  Connect »

Research Site

Toulouse, France
  Connect »

Research Site

Tours CEDEX, France
  Connect »

Research Site

Villejuif, France
  Connect »

Research Site

Bielefeld, Germany
  Connect »

Research Site

Dresden, Germany
  Connect »

Research Site

Duisburg, Germany
  Connect »

Research Site

Düsseldorf, Germany
  Connect »

Research Site

Erlangen, Germany
  Connect »

Research Site

Guetersloh, Germany
  Connect »

Research Site

Hamburg, Germany
  Connect »

Research Site

Lübeck, Germany
  Connect »

Research Site

Muenster, Germany
  Connect »

Research Site

Münster, Germany
  Connect »

Research Site

Rostock, Germany
  Connect »

Research Site

Stuttgart, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Wiesbaden, Germany
  Connect »

Research Site

Würzburg, Germany
  Connect »

Research Site

Goyang-si, Korea, Republic of
  Connect »

Research Site

Seo-Gu, Korea, Republic of
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Leeuwarden, Netherlands
  Connect »

Research Site

Leiden, Netherlands
  Connect »

Research Site

Tilburg, Netherlands
  Connect »

Research Site

Basel, Switzerland
  Connect »

Research Site

Bern, Switzerland
  Connect »

Research Site

Genolier, Switzerland
  Connect »

Research Site

Glasgow, United Kingdom
  Connect »

Research Site

London, United Kingdom
  Connect »

Research Site

Newcastle, United Kingdom
  Connect »

Research Site

Plymouth, United Kingdom
  Connect »

Research Site

Preston, United Kingdom
  Connect »

Research Site

Sheffield, United Kingdom
  Connect »

Research Site

Besançon Cedex, France
  Connect »

Research Site

Düsseldorf, Germany
  Connect »

Research Site

Lübeck, Germany
  Connect »

Research Site

Münster, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Würzburg, Germany
  Connect »

Research Site

Besançon Cedex, France
  Connect »

Research Site

Düsseldorf, Germany
  Connect »

Research Site

Lübeck, Germany
  Connect »

Research Site

Münster, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Würzburg, Germany
  Connect »

Research Site

Besançon Cedex, France
  Connect »

Research Site

Düsseldorf, Germany
  Connect »

Research Site

Lübeck, Germany
  Connect »

Research Site

Münster, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Würzburg, Germany
  Connect »

Research Site

Besançon Cedex, France
  Connect »

Research Site

Bordeaux, France
  Connect »

Research Site

Düsseldorf, Germany
  Connect »

Research Site

Lübeck, Germany
  Connect »

Research Site

Münster, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Würzburg, Germany
  Connect »

Research Site

Besançon Cedex, France
  Connect »

Research Site

Düsseldorf, Germany
  Connect »

Research Site

Lübeck, Germany
  Connect »

Research Site

Münster, Germany
  Connect »

Research Site

Tübingen, Germany
  Connect »

Research Site

Würzburg, Germany
  Connect »